glp-1 and kidney receptor agonists next-generation metabolic hormone therapies in chronic disease GLP-1 drugs may extend life,

While the primary patents on the albuterol molecule expired decades ago (in 1989), Teva maintained exclusivity through a fortress of secondary patents covering the hydrofluoroalkane (HFA) propellant formulation and the intricate mechanics of the inhaler device itself

When intake explains the result and the patient is well, with no concerning clinical or laboratory findings,it can often be attributed as the likely cause without an extensive search for disease

doi:10.1590/1981-863720180003000083517 Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J

I had a blood test recently that revealed excess vitamin B12

It adds bulk to stool and accelerates intestinal transit

No lethal dose was established, suggesting a wide safety margin